Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
CStone Pharmaceuticals
Scientific Title
A Phase Ia/Ib, Open-Label, Multiple-Dose, Dose-Escalation and Expansion Study of the Anti-PD-1 Monoclonal Antibody CS1003 in Subjects With Advanced Solid Tumors